This bioscience company has had promising financials, yet one of its top executives exited his entire direct equity ownership in mid-January 2026.

A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual performance ever in 2025.

Justin Bieber makes his Grammys comeback, Ye stirs rumours of another potential red carpet stunt, and hopes are high for ...